Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability

por Qi Wang, Jianwei He, Dallas B. Flies, Liqun Luo, Lieping Chen
Publicado 2017

Human Semaphorin-4A drives Th2 responses by binding to receptor ILT-4

por Ning Lu, Ying Li, Zhiqiang Zhang, Junji Xing, Ying Sun, Sheng Yao, Lieping Chen
Publicado 2018

A monoclonal antibody against KCNK9 K+ channel extracellular domain inhibits tumour growth and metastasis

por Han Sun, Liqun Luo, Bachchu Lal, Xinrong Ma, Lieping Chen, Christine L. Hann, Amy M. Fulton, Daniel J. Leahy, John Laterra, Min Li
Publicado 2016

An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion

por Gehua Zhen, Yang Dan, Ruomei Wang, Ce Dou, Qiaoyue Guo, Melissa Zarr, Linda N. Liu, Lieping Chen, Ruoxian Deng, Yusheng Li, Zengwu Shao, Xu Cao
Publicado 2021

Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy

por Ying Li, Yanni Cong, Mingming Jia, Qianqian He, Haiqing Zhong, Yun Zhao, Hang Li, Meining Yan, Jia You, Jia Liu, Lieping Chen, Haiying Hang, Shengdian Wang
Publicado 2021

YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment

por Xiaochen Yang, Wing Lam, Zaoli Jiang, Fulan Guan, Xue Han, Rong Hu, Wei Cai, William Cheng, Shwu-Huey Liu, Peikwen Cheng, Yuping Cai, Nicholas J. W. Rattray, Caroline H. Johnson, Lieping Chen, Yung-Chi Cheng
Publicado 2021